Clinical Trial Update: Ghrelin for Alcohol Use in Non-Treatment-Seeking Heavy Drinkers [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating ghrelin for reducing alcohol use in heavy drinkers who are not seeking treatment; study completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Dependence
• Alcohol Use Disorder
• Alcoholism

Snippet

Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Conditions: fMRI, Alcohol Drinking | Phase 2 | Status: COMPLETED | Results posted: 2018-08-03